[The marking of the gastrointestinal tract in computed tomography: experiences with a barium sulfate contrast medium (Micropaque CT)].
Micropaque CT, a new suspension of barium sulphate, has recently become available for clinical use in abdominal CT. The attenuation of the 1.5 per cent solution, measured in vitro, was 222 HU (without artifacts). In about 45 per cent of the clinical examinations artifacts occurred which, however, were not disturbing. Sufficient opacification of stomach and bowel was achieved in 65 per cent. 55 per cent of patients found the suspension pleasant to take, ten per cent complained of mild diarrhoea. Micropaque CT is particularly suitable for upper abdominal CT in outpatients.
Golder
W
W
Institut für Röntgendiagnostik, Technische Universität München, Klinikum rechts der Isar.
Viermetz
M
M
Gmeinwieser
J
J
D000328:Adult; D000368:Aged; D001466:Barium Sulfate; D003470:Culture Media; D004064:Digestive System / Q000000981:diagnostic imaging*; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D005260:Female; D006801:Humans; D007479:Iopamidol; D007483:Iothalamic Acid / Q000031:analogs & derivatives; D008297:Male; D008875:Middle Aged; D013535:Suspensions; D014057:Tomography, X-Ray Computed / Q000379:methods*
D003470:Culture Media; D013535:Suspensions; D007483:Iothalamic Acid; D001466:Barium Sulfate; C002587:ioxitalamic acid; D007479:Iopamidol
Markierung des Gastrointestinaltrakts bei der Computertomographie: Erfahrungen mit einem bariumsulfathaltigen Kontrastmittel (Micropaque CT).